McCulloch Kevin: insider trades.
McCulloch Kevin reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.2M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- McCulloch Kevin
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | Officer · See Remarks | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | Xeris Biopharma Holdings, Inc. | S | 25,000 | $10 | 1,614,208 | Form 4 |
| 2026-09-01 | Xeris Biopharma Holdings, Inc. | S | 15,000 | $8.49 | 1,639,208 | Form 4 |
| 2026-08-03 | Xeris Biopharma Holdings, Inc. | S | 15,000 | $8.02 | 1,676,126 | Form 4 |
| 2026-08-01 | Xeris Biopharma Holdings, Inc. | F | 21,918 | $8.08 | 1,654,208 | Form 4 |
| 2026-07-01 | Xeris Biopharma Holdings, Inc. | S | 90,000 | $8.03 | 1,691,126 | Form 4 |
Questions
What stock did McCulloch Kevin buy or sell?
McCulloch Kevin reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($1.2M), across 1 company.
Is McCulloch Kevin the same person as other filers with this name?
This page covers SEC CIK 2031695 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mcculloch-kevin-2031695.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.